St Louis, MONCT06274528Now EnrollingIRB Ready

Alzheimer Disease Clinical Trial in St Louis, MO

Access cutting-edge alzheimer disease treatment through this phase 2 clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.

Sponsored by Washington University School of Medicine

Quick Self-Assessment

See if you qualify for this St Louis location

Preparing your pre-screening questions…

Expert Care in St Louis

Access alzheimer disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related alzheimer disease treatment provided free

Apply for This St Louis Location

Check if you qualify for this alzheimer disease clinical trial in St Louis, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to St Louis

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit St Louis site if eligible
  4. 4Begin participation

About This Alzheimer Disease Study in St Louis

The purpose of this study is to see if the sleep aid, lemborexant, can decrease the amount of amyloid-beta and tau in the blood. Amyloid-beta and tau are proteins involved in the disease process leading to Alzheimer's disease.

Sponsor: Washington University School of Medicine

Who Can Participate

Inclusion Criteria

Male or female.
Any race or ethnicity.
Participants must be age ≥ 65 years and able to sign informed consent.
Global Clinical Dementia Rating (CDR) 0.
Willing and able to undergo study procedures.

Exclusion Criteria

History or reported symptoms suggestive of restless legs syndrome, narcolepsy, or parasomnia.
STOP-Bang score \>6 for participants without PAP.
Untreated sleep apnea AHI\>15
Poorly treated sleep apnea due to noncompliance or an AHI ≥ 10. \- PAP compliance is defined as ≥ 4 hours per night \>70% of the nights.
Plasma p-Tau217/np-Tau217% \<2.5
History of renal impairment
Defined as older adult patients with markers of kidney damage or eGFR \< 45.0 ml/min/1.73m2.
Normal Limits ≥ 45.0 mL/min/1.73m2
History of hepatic impairment
AST and/or ALT ≥ 2X upper limit of normal (ULN).
Normal Limits: AST 11-47 IU/L and ALT 6-53 IU/L
History of substance abuse or alcohol abuse in the preceding 6 months.
Regular alcohol consumption 3 or more days a week over the last 6 months. Regular alcohol consumption is defined as having more than 2 alcoholic beverages within 3 hours of bedtime. Participants that agree to reduce alcohol consumption during the study may not be excluded.
History of presence of any clinically significant medical condition, behavioral or psychiatric disorder, or surgical history based on medical record or participant report that could affect the safety of the participant or interfere with study assessments or in the judgement of the Principal-Investigator (PI) if participant is not a good candidate.
Has any medical condition that, in the PI's or study team investigator's opinion, could increase risk to the participant, limit the participant's ability to tolerate the research procedures, or interfere with the collection/analysis of the data. Potential medical conditions that will be exclusionary at the PI's or study team investigator's discretion:
Cardiovascular disease requiring medication except for controlled hypertension.
Pulmonary disease.
Type I diabetes.
Neurologic or psychiatric disorder requiring medication.
Untreated depression
Tobacco use.
Use of sedating medications.
Use of medications that interact with lemborexant (if cannot be discontinued).
Abnormal safety labs.
History of current suicidal ideations.
Inability to speak and understand English.
Currently pregnant or breast-feeding.
In the opinion of the PI, the participant should be excluded due to an abnormal physical examination.
Must not have participated in any clinical trial involving a study drug or device within the 30-days prior to study enrollment.
Must not participate in another drug or device study prior to the end of this study participation. Optional assessment exclusion criteria: • Contraindication to lumbar puncture (anticoagulants; bleeding disorder; allergy to lidocaine or disinfectant; prior central nervous system or lower back surgery).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in St Louis?

Yes, this clinical trial (NCT06274528) has an active research site in St Louis, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Alzheimer Disease Treatment Options in St Louis, MO

If you're searching for alzheimer disease treatment options in St Louis, MO, this clinical trial (NCT06274528) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our St Louis research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced alzheimer disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all alzheimer disease clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in St Louis, MO

See all alzheimers disease clinical trials recruiting in St Louis — not just this study.

Browse Alzheimers Disease Trials in St Louis →

Browse More Trials by Condition

Alzheimers Disease TrialsAnkylosing Spondylitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in St Louis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · St Louis, MO